Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
—
Political receipts
—
Lobbying income
—
Lobbying expense
—
Federal awards
—
Relationships
23
| insider of | Epizyme, Inc. | 24,013,579.8 | Jun 5, 2013 – Jan 12, 2016 |
| insider of | Millennial Media Inc. | 21,474,257.28 | Apr 3, 2012 – Oct 29, 2012 |
| insider of | Clovis Oncology, Inc. | 17,111,887 | Nov 21, 2011 – Jun 3, 2013 |
| insider of | Mersana Therapeutics, Inc. | 15,000,000 | Jul 3, 2017 – Jul 3, 2017 |
| insider of | Omthera Pharmaceuticals, Inc. | 10,068,882.5 | Apr 11, 2013 – Jul 18, 2013 |
| insider of | Tracon Pharmaceuticals, Inc. | 9,999,998.75 | Feb 4, 2015 – Nov 29, 2016 |
| insider of | Inc. Synlogic | 9,997,494 | Oct 5, 2015 – Jan 26, 2018 |
| insider of | Rhythm Pharmaceuticals, Inc. | 9,350,000 | Oct 10, 2017 – Oct 10, 2017 |
| insider of | Inc. Aveo Pharmaceuticals | 8,165,118.66 | Mar 28, 2017 – Aug 21, 2018 |
| insider of | Achaogen, Inc. | 6,750,000 | Dec 19, 2016 – Dec 19, 2016 |
| insider of | Cascadian Therapeutics, Inc. | 5,999,400 | Feb 20, 2018 – Mar 9, 2018 |
| insider of | Roka BioScience, Inc. | 4,599,996 | Jul 22, 2014 – Sep 21, 2016 |
| insider of | Ra Pharmaceuticals, Inc. | 4,411,307.06 | Oct 31, 2016 – Oct 31, 2016 |
| insider of | Interleukin Genetics Inc | 3,998,968.9 | Dec 23, 2014 – Jul 29, 2016 |
| insider of | Loxo Oncology, Inc. | 2,999,997 | Aug 6, 2014 – Aug 6, 2014 |
| insider of | Surface Oncology, Inc. | 1,999,995 | Apr 23, 2018 – Apr 23, 2018 |
| insider of | Dermira, Inc. | 1,105,792 | Oct 8, 2014 – Oct 8, 2014 |
| insider of | Oruka Therapeutics, Inc. | 730,104.5 | Feb 26, 2018 – Feb 26, 2018 |